26 results
Plasmacytomas and Plasma-Cell Leukemia - Physical examination revealed multiple exophytic subcutaneous lesions involving the arms and
Plasmacytomas and Plasma-Cell ... revealed 25% plasma cells ... stain) #Clinical #HONC ... Leukemia #Smear #NEJM
Hemolysis in Hereditary Spherocytosis. Panel A shows the structure of a normal red cell and a
spleen in which red cells ... between endothelial cells ... Pathophysiology #Honc ... #IM #Spherocytosis ... HereditarySpherocytosis #NEJM
Nephron Remodeling as a Mechanism of Diuretic Resistance. When high doses of loop diuretics are used
convoluted tubule cells ... , principal cells ... and intercalated cells ... Pathophysiology #Nephro #IM ... NephronRemodeling #NEJM
Activated T-Cell Killing a Cancer Cell

#TCell #Killing #Cancer #Cells #clinical #microscopy #video
Activated T-Cell ... Killing a Cancer ... #Killing #Cancer ... #Cells #clinical ... #microscopy #video
Activated T-Cell Killing a Cancer Cell

#TCell #Killing #Cancer #Cells #clinical #microscopy #video
Activated T-Cell ... Killing a Cancer ... Cell #TCell #Killing ... #Cancer #Cells ... #clinical #microscopy
Multiple Myeloma Diagnosis and Management Summary
Clinical Signs:
 • hyperCalcemia 28% (bone demineralization)
 • Renal disease 48%
Diagnosis and Management ... marrow plasma cells ... plasma clonal cell ... also >100 CMC IM ... Myeloma #Diagnosis #Management
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
ALK-Positive Non–Small-Cell ... Lung Cancer #EBM ... #Honc #Alectinib ... VisualAbstract #NEJM
Immunosuppressive Strategies for the Prevention or Treatment of Acute GVHD. Panel A shows several classic immunosuppressive
antigen-presenting cell ... of activated T cells ... Pathophysiology #IM ... #Honc #Pharm #GVHD ... Immunosuppression #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
III Non–Small-Cell ... Lung Cancer - Progression-free ... #EBM #Honc #PACIFIC ... Durvalumab #NSCLC #NEJM
Acquired von Willebrand Syndrome - Diagnosis and Management
 • Autoantibodies to vWF: Lymphoproliferative disorders (e.g. lymphoma,
Diagnosis and Management ... adsorption onto cancer ... cells (and subsequent ... Syndrome #Diagnosis #Management